**Core Concept**
Alendronate is a bisphosphonate drug used in the treatment of osteoporosis and other bone diseases. It works by inhibiting osteoclast-mediated bone resorption, thus increasing bone density and reducing the risk of fractures.

**Why the Correct Answer is Right**
Alendronate acts by selectively inhibiting the enzyme farnesyl pyrophosphate synthase (FPPS), which is involved in the mevalonate pathway. This pathway is crucial for the post-translational modification of proteins, including the prenylation of small GTPases such as Ras and Rho. By inhibiting FPPS, alendronate prevents the prenylation of these GTPases, which are essential for the activation of osteoclasts. As a result, osteoclast activity is reduced, leading to decreased bone resorption and increased bone density.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely incorrect because it does not accurately describe the mechanism of action of alendronate.
**Option B:** This option is incorrect because alendronate does not act by stimulating osteoblasts, which are cells involved in bone formation.
**Option C:** This option is incorrect because alendronate does not directly inhibit the activity of osteoclasts; rather, it reduces their activation by inhibiting the mevalonate pathway.

**Clinical Pearl / High-Yield Fact**
Bisphosphonates like alendronate are effective in treating osteoporosis because they target the osteoclasts, which are primarily responsible for bone resorption. This is in contrast to other treatments that may target osteoblasts or other bone-related cells.

**Correct Answer:** D